Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD93 orchestrates the tumor microenvironment and predicts the molecular subtype and therapy response of bladder cancer.

Computers in biology and medicine - 1 Aug 2022

Zheng Xiaonan, Xu Hang, Lin Tianhai, Tan Ping, Xiong Qiao, Yi Xianyanling, Qiu Shi, Yang Lu, Shen Bairong, Ai Jianzhong, Wei Qiang

Abstract excerpt

BACKGROUND: CD93 is newly reported to normalize vasculature and attenuate pancreatic cancer therapy response, but its role in bladder cancer (BLCA) is unknown. METHOD: The immunologic role of CD93 is analyzed across TCGA pan-cancers. The correlation between CD93 and BLCA clinical and tumor microenvironment features, predicted immunotherapy pathways, molecular subtypes, therapeutic signatures and mutation status...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Tumor Microenvironment

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 35785664
DOI: 10.1016/j.compbiomed.2022.105727

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD93 orchestrates the tumor microenvironment and predicts the molecular subtype and therapy response of bladder cancer.PMID 35785664Read ↗

Investigating the impact of regulatory B cells and regulatory B cell-related genes on bladder cancer progression and immunotherapeutic sensitivitySemantic proximity Read ↗

An IFN-γ-related signature predicts prognosis and immunotherapy response in bladder cancer: Results from real-world cohortsSemantic proximity Read ↗

Integrating Stemness Features and Immune Microenvironment in a Prognostic Model for Bladder Cancer TreatmentSemantic proximity Read ↗

Multi-omics profiling and digital image analysis reveal the potential prognostic and immunotherapeutic properties of CD93 in stomach adenocarcinomaSemantic proximity Read ↗

Three Conserved Immune Dysfunction and Exclusion Subtypes in Bladder and Pan-cancers: Prognostic and Immunotherapeutic SignificanceSemantic proximity Read ↗

Identification of endothelial-related molecular subtypes for bladder cancer patientsSemantic proximity Read ↗

The Immunogenomic Landscape of and Immune Cell Infiltration in Bladder CancerSemantic proximity Read ↗

Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.Semantic proximity Read ↗

Single-cell and bulk RNA-sequence identiﬁed ﬁbroblasts signature and CD8 + T-cell - ﬁbroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine learning: bioinformatics multi-omics studySemantic proximity Read ↗

An Evaluation of the Tumor Microenvironment through CALR, IL1R1, IFNB1, and IFNG to Assess Prognosis and Immunotherapy Response in Bladder Cancer PatientsSemantic proximity Read ↗

Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironmentSemantic proximity Read ↗

Integrating molecular subtype and CD8+ T cells infiltration to predict treatment response and survival in muscle-invasive bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.